5 Biotech Stocks At Rock Bottom Price With Takeover Possibility

May 11, 2012  | 2 comments  |  includes: AEZS, AKRX, CHTP, KERX, MRK, ONTY, SPPI, VPHM, WPI

In this article, I will focus on 5 biotechnology and drug companies that have negative price performance for the year 2012. Investors like to buy the stocks at a rock bottom price that have growth potential. When the stock price is at bottom, it also creates a potential takeover opportunity from its competitors to leverage the discounted price as well as to accelerate the drug developments from these companies. Click here to read more